Pharmaceutical and Life Sciences Real World Evidence Market Size
Market Size in USD Bn
CAGR15.2%
| Study Period | 2025-2032 |
| Base Year of Estimation | 2024 |
| CAGR | 15.2% |
| Market Concentration | Medium |
| Major Players | Clinerion, Clinigen Group, Cognizant Analytics, Evidera, HealthCore and Among Others |
*Disclaimer: Major players are listed in no particular order.
*Source: Coherent Market Insights
Want to purchase customized report?
please let us know !
please let us know !
Pharmaceutical and Life Sciences Real World Evidence Market Analysis
The Pharmaceutical and Life Sciences Real World Evidence Market is estimated to be valued at USD 2.30 billion in 2025 and is expected to reach USD 6.19 billion by 2032, growing at a compound annual growth rate (CAGR) of 15.2% from 2025 to 2032.
The market is witnessing positive trends owing to rise in usage of real-world data to assess relative effectiveness and safety of treatment options. Pharmaceutical companies are increasingly leveraging real world evidence to expedite clinical development, better target patient populations, and improve health outcomes.